TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

Friday’s trading has closed, but TXMD is being traded in the after-hours session. After-Hours quote »
5.06
Delayed Data
As of 4:01pm ET
 -0.15 / -2.88%
Today’s Change
3.42
Today|||52-Week Range
9.01
+13.71%
Year-to-Date
No recent news for TherapeuticsMD Inc.

Today’s Trading

Previous close5.21
Today’s open5.16
Day’s range5.03 - 5.22
Volume979,573
Average volume (3 months)1,016,085
Market cap$884.0M
Dividend yield--
Data as of 4:01pm ET, 03/06/2015

Growth & Valuation

Earnings growth (last year)+42.11%
Earnings growth (this year)-59.09%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+129.85%
P/E ratioNM
Price/Sales75.74
Price/Book13.81

Competitors

 Today’s
change
Today’s
% change
SGNTSagent Pharmaceutica...-0.36-1.31%
RGENRepligen Corp-0.71-2.75%
EPZMEpizyme Inc-1.41-5.78%
FOLDAmicus Therapeutics ...-0.16-1.85%
Data as of 4:00pm ET, 03/06/2015

Financials

Next reporting dateMarch 10, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$8.8M
Annual profit (last year)-$28.4M
Net profit margin-323.84%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President, Secretary &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account